Our Research Expertise
Alzheimer's disease
17 separate clinical trials
Enrolled over 420 patients in our Alzheimer’s trials; randomized over 140
Access to certified laboratories, dermatologists, ophthalmologists, and MRI/PET facilities
Vaccines
Over 3500 patients randomised in the last 15 years
34 studies; 7 Phase I-II, 25 Phase III-IV and 2 non-interventional
Areas: pandemic (COVID-19 and seasonal influenza), zona, tetanus, diphtheria, hepatitis B, human papilloma virus and pneumozoster
Blood sampling
and laboratory studies
Over 800 participants screened in the past 3 years
Blood and plasma donations coordinated to meet the requirements of medical research protocols
In-House Plasmapheresis Unit
Enables obtaining frequent and large volumes of plasma
Capacity of 18 procedures per day
PBMC Harvesting
15 studies utilized the in-house capability for cell isolation and N2 cryopreservation
Team of 3 staff trained for procedure
Capacity of 16 samples per day
Other